"
Effect of Angiotensin Receptor-Neprilysin Inhibitor versus Valsartan on Cardiac Status in Patients with Chronic Heart Failure with Reduced Ejection Fraction: A Randomized Clinical Trial in Rangpur Medical College Hospital, Bangladesh"
written by Shakil Ghafur, Md. Abu Zahid, Haripada Sarkar, Rabindra Nath Barman, Abdullah Al-Mahmud, Mahbubur Rahman, Hasanul Islam,
published by
Open Journal of Internal Medicine,
Vol.10 No.1, 2020
has been cited by the following article(s):
|
[1]
|
Association between angiotensin receptor-neprilysin inhibitor use and clinical outcomes in patients with heart failure: a 1-year prospective cohort study from Jordan
BMJ Open,
2026
DOI:10.1136/bmjopen-2025-111865
|
|
|
|
|
[2]
|
Cardiorenal safety and efficacy of angiotensin receptor‑neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta‑analysis and meta‑regression of RCTs with 28,001 patients
Biomedical Reports,
2025
DOI:10.3892/br.2025.2096
|
|
|
|
|
[3]
|
Comparison of Efficacy and Safety of Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis
Cureus,
2023
DOI:10.7759/cureus.36392
|
|
|
|